Implementing Quality Practices to Avoid Medication Error for Methotrexate

Date of Original Release: December 20, 2022
Date of Expiration: December 20, 2025
Estimated Time of Completion:  30 minutes

Target Audience
Dermatologists and others involved in the delivery of dermatologic care.

Statement of Need
The American Academy of Dermatology bases its CME activities on identified professional practice gaps, the educational needs which underlie these gaps, and emerging clinical research findings as these relate to dermatology. Learners should reflect upon clinical and scientific information presented in this CME activity and determine the need for further study.

Learning Objectives
Following participation in this activity, the learner should be able to:

• Describe case of adverse event associated with common medication error in prescribing methotrexate
• Identify root causes for safety event
• Discuss strategies for process improvement

Accreditation Statement
The American Academy of Dermatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

AMA PRA Credit Statement
The American Academy of Dermatology designates this Enduring material for a maximum of .5 AMA PRA Category 1 Credit^TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Instructions to Claim Credit
To Claim CME credit for this activity, the learner must complete the post-activity quiz achieving a 70% passing score and an evaluation survey.

Planners

Hillary Johnson-Jahangir, MD, PhD, FAAD
Clinical Associate Professor
University of Iowa
Iowa City, IA

Mona El-Shamaa
Manager, Quality Improvement
Rosemont, IL
Rosemont, IL

Arielle Nagler, MD, FAAD
Assistant Professor
The Ronald O. Perelman Department of Dermatology
NYU School of Medicine
New York, NY

Syril Que, MD, MPH, FAAD
Fellow in Micrographic Surgery and Dermatologic Oncology
Brigham and Women's Hospital
Boston, MA

Margo Reeder, MD, FAAD
Assistant Professor
University of Wisconsin School of Medicine and Public Health
Madison, WI

Sara Samimi, MD, FAAD
Associate Professor
University of Pennsylvania
Philadelphia PA

Brittney Schultz, MD, FAAD
Assistant Professor
University of Minnesota
Minneapolis, MN

Gideon Smith, MD, FAAD
Vice Chief for Clinical Affairs
Dept of Dermatology
Mass General Hospital
Harvard Medical School
Boston, MA

Speaker

Lindsay Strowd, MD, FAAD
Associate Professor and Vice Chair of Dermatology
Wake Forest University School of Medicine
Winston-Salem, NC

Reviewer(s)

Mona El-Shamaa
Manager, Quality Improvement
Rosemont, IL
Rosemont, IL

Staff

Mona El-Shamaa
Manager, Quality Improvement
Rosemont, IL
Rosemont, IL

Christine Presta – Associate Director, Digital Learning
American Academy of Dermatology
Rosemont, IL

Dustin Herlich- Manager, Digital Learning
American Academy of Dermatology
Rosemont, IL

Dana Bell – Instructional Designer
Nashville, TN

Melinda Keske – Sr. Coordinator, Digital Learning
American Academy of Dermatology
Rosemont, IL

Disclosures

All other planners, speakers, reviewers, and staff for this activity have no relevant financial relationships with ineligible companies (formerly known as commercial interests).

Conflict Mitigation Statement
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, the American Academy of Dermatology has implemented mechanisms, prior to the planning implementation of this activity, to identify and mitigate conflicts of interest for all individuals in a position to control the content.

Unapproved Use Disclosure
The American Academy of Dermatology requires CME faculty/authors to disclose to learners when products or procedures are being discussed are off-label (not approved for the indications being discussed), unlabeled (not approved for any indications), experimental and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these products/procedures. If you have questions, contact the medical affairs department of the manufacturer for the most recent approval information. Faculty/authors of this activity may be discussing information about pharmaceutical agents that is outside of the U.S. Food and Drug Administration approved labeling.

Disclaimer
The American Academy of Dermatology (AAD) is not responsible for statements made by the author(s). Statement or opinions expressed in this activity reflect the views of the author(s) and do not reflect the official policy of the AAD. The information provided in this CME activity is for continuing education purposes only, is not intended to establish a standard of care, and is not meant to substitute for independent medical judgment of a health provider relative to the diagnostic, management and treatment options of a specific patient’s medical condition. 

No Medical Advice
The information in this publication by the American Academy of Dermatology or any third party should not be considered medical advice and is not intended to replace consultation with a qualified dermatology professional. The American Academy of Dermatology does not answer specific medical questions or refer people to a particular dermatology professional.

Contact Information
For the American Academy of Dermatology Member Resource Center, please call (866) 503-7546.